Overview

• US healthcare and tech solutions provider's Q1 revenue fell 29% yr/yr, driven by lower reimbursement rates

• Gross margin for Q1 rose to a record 35%, boosted by new contracted medication fulfillment services

• Company cut operating expenses 9% sequentially, narrowing net loss by 42% yr/yr

Outlook

• Company expects positive operating income in the latter half of 2026

• Healthcare segment gross margin anticipated to remain elevated through 2026

• Company plans to launch new healthcare e-commerce site before end of Q2 2026

Result Drivers

• LOWER REIMBURSEMENT RATES - Co said healthcare revenue fell due to lower reimbursement rates and a contraction in prescription volume

• CONTRACTED SERVICES & DRUG COSTS - Gross margin rose due to new contracted medication fulfillment services and improved drug costing from the Medicare Maximum Fair Price program

• EXPENSE REDUCTIONS - Operating expenses declined due to reductions in headcount, executive compensation, and professional fees

Company press release: ID:nPnBV92ha

Key Details

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.